SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-24-023230
Filing Date
2024-06-10
Accepted
2024-06-07 20:15:31
Documents
8
Effectiveness Date
2024-06-10

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 220417
2 ex5-1.htm EX-5.1 13819
3 ex23-1.htm EX-23.1 4724
4 ex23-2.htm EX-23.2 3239
5 ex99-2.htm EX-99.2 75934
6 CALCULATION OF FILING FEE TABLE ex107.htm EX-FILING FEES 54885
7 forms-8_001.jpg GRAPHIC 1774
8 ex5-1_001.jpg GRAPHIC 2286
  Complete submission text file 0001493152-24-023230.txt   380025
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280075 | Film No.: 241031242
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)